State Street Corporation 13D and 13G filings for TG Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-13 12:23 pm Sale | 2025-03-31 | 13G | TG Therapeutics, Inc. TGTX | STATE STREET CORP STT | 7,433,899 4.700% | -819,674 (-9.93%) | Filing |
| 2024-01-25 11:29 am Sale | 2023-12-31 | 13G | TG Therapeutics, Inc. TGTX | STATE STREET CORP STT | 8,253,573 5.450% | -2,161,588 (-20.75%) | Filing |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | TG Therapeutics, Inc. TGTX | STATE STREET CORP STT | 10,415,161 7.170% | 7,009,856 (+205.85%) | Filing |